Literature DB >> 16324919

Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men.

Rie Mitsui1, Mitsuo Fukushima, Yuichi Nishi, Naoya Ueda, Haruhiko Suzuki, Ataru Taniguchi, Yoshikatsu Nakai, Toshiko Kawakita, Takeshi Kurose, Yuichiro Yamada, Nobuya Inagaki, Yutaka Seino.   

Abstract

Hyperglycemia frequently continues to worsen even after the diagnosis of overt diabetes. The aim of this study is to evaluate the factors contributing to increasing glucose intolerance after onset of type 2 diabetes in Japanese subjects. Five hundred fifty newly diagnosed type 2 diabetic patients were classified into 3 degrees of hyperglycemia based on plasma glucose levels estimated by 75-g oral glucose tolerance test: diabetes mellitus with isolated fasting hyperglycemia (DM/IFH), DM with isolated postchallenge hyperglycemia (DM/IPH), and DM with fasting and postchallenge hyperglycemia (DM/FPH). In addition, the DM/IFH and DM/IPH groups were subdivided to clarify the determinants of fasting and postchallenge hyperglycemia. Insulin secretion was evaluated by insulinogenic index, and insulin sensitivity was evaluated by composite index of insulin sensitivity (ISI composite). The insulinogenic index in DM/IFH was highest of the 3 groups (P < .0001). The insulinogenic index in DM/IPH was higher than in DM/FPH (P < .0001). The international sensitivity index composite in DM/IPH was highest of the 3 groups (P < .05). Although impaired early-phase insulin secretion plays the crucial role in deterioration from DM/IFH to DM/FPH in Japanese subjects, impaired early-phase insulin secretion and decreased insulin sensitivity both are factors in deterioration from DM/IPH to DM/FPH. In addition, comparison of subgroups of DM/IFH and DM/IPH shows that although decreased early-phase insulin secretion plays the more significant role in postchallenge hyperglycemia in Japanese subjects, insulin sensitivity is the more important factor in fasting hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16324919     DOI: 10.1016/j.metabol.2005.07.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients.

Authors:  Junji Kozawa; Hiromi Iwahashi; Kohei Okita; Yukiyoshi Okauchi; Akihisa Imagawa; Iichiro Shimomura
Journal:  Diabetes Ther       Date:  2011-01-19       Impact factor: 2.945

2.  Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride.

Authors:  Shuang Zheng; Huan Zhou; Tingting Han; Yangxue Li; Yao Zhang; Wei Liu; Yaomin Hu
Journal:  BMC Endocr Disord       Date:  2015-04-29       Impact factor: 2.763

3.  Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese.

Authors:  Rie Mitsui; Mitsuo Fukushima; Ataru Taniguchi; Yoshikatsu Nakai; Sae Aoyama; Yoshitaka Takahashi; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Toshiko Kawakita; Yutaka Seino; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2012-08-20       Impact factor: 4.232

4.  Plasma gastric inhibitory polypeptide and glucagon-like peptide-1 levels after glucose loading are associated with different factors in Japanese subjects.

Authors:  Norio Harada; Akihiro Hamasaki; Shunsuke Yamane; Atsushi Muraoka; Erina Joo; Kazuyo Fujita; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2011-06-05       Impact factor: 4.232

5.  Efficacy and safety of patient-directed titration of once-daily pre-dinner premixed biphasic insulin aspart 70/30 injection in Japanese type 2 diabetic patients with oral antidiabetic drug failure: STEP-AKITA study.

Authors:  Takuma Narita; Takashi Goto; Yumi Suganuma; Mihoko Hosoba; Tsukasa Morii; Takehiro Sato; Hiroki Fujita; Takeshi Miura; Takashi Shimotomai; Yuichiro Yamada; Masafumi Kakei
Journal:  J Diabetes Investig       Date:  2011-01-24       Impact factor: 4.232

6.  Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus.

Authors:  Tomoyuki Katsuno; Nobuaki Watanabe; Etsuko Nagai; Kazumi Okazaki; Ariko Yokoyama; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  J Diabetes Investig       Date:  2011-06-05       Impact factor: 4.232

7.  Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus.

Authors:  Sae Aoyama-Sasabe; Xin Xin; Ataru Taniguchi; Yoshikatsu Nakai; Rie Mitsui; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Nobuya Inagaki; Yutaka Seino; Mitsuo Fukushima
Journal:  J Diabetes Investig       Date:  2014-05-12       Impact factor: 4.232

8.  Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study.

Authors:  Hiroaki Ikezaki; Masumi Ai; Ernst J Schaefer; Seiko Otokozawa; Bela F Asztalos; Katsuyuki Nakajima; Yanhua Zhou; Ching-Ti Liu; Paul F Jacques; L Adrienne Cupples; Norihiro Furusyo
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

9.  Identification of putative biomarkers for prediabetes by metabolome analysis of rat models of type 2 diabetes.

Authors:  Norihide Yokoi; Masayuki Beppu; Eri Yoshida; Ritsuko Hoshikawa; Shihomi Hidaka; Toshiya Matsubara; Masami Shinohara; Yasuhiro Irino; Naoya Hatano; Susumu Seino
Journal:  Metabolomics       Date:  2015-03-12       Impact factor: 4.290

Review 10.  Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus.

Authors:  Hiroyuki Konya; Tomoyuki Katsuno; Taku Tsunoda; Yuzo Yano; Mai Kamitani; Masayuki Miuchi; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  Diabetes Metab Syndr Obes       Date:  2013-09-02       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.